

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitotic chromosome condensation (GO:0007076) | 6.77680663 |
| 2 | nuclear pore complex assembly (GO:0051292) | 6.77442247 |
| 3 | nuclear pore organization (GO:0006999) | 6.01894915 |
| 4 | DNA unwinding involved in DNA replication (GO:0006268) | 5.73909342 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.71239411 |
| 6 | mitotic sister chromatid segregation (GO:0000070) | 5.23179437 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.15893342 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.15893342 |
| 9 | sister chromatid segregation (GO:0000819) | 5.09527016 |
| 10 | pore complex assembly (GO:0046931) | 4.96153346 |
| 11 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.90422779 |
| 12 | protein localization to chromosome, centromeric region (GO:0071459) | 4.89056036 |
| 13 | protein localization to kinetochore (GO:0034501) | 4.88374882 |
| 14 | DNA strand elongation (GO:0022616) | 4.75867371 |
| 15 | DNA replication initiation (GO:0006270) | 4.69792370 |
| 16 | DNA topological change (GO:0006265) | 4.62164525 |
| 17 | mitotic metaphase plate congression (GO:0007080) | 4.58668362 |
| 18 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.43259546 |
| 19 | mitotic nuclear envelope disassembly (GO:0007077) | 4.40790104 |
| 20 | mitotic sister chromatid cohesion (GO:0007064) | 4.37397882 |
| 21 | DNA replication checkpoint (GO:0000076) | 4.28123121 |
| 22 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 4.27963100 |
| 23 | chromosome condensation (GO:0030261) | 4.27256077 |
| 24 | hepatocyte apoptotic process (GO:0097284) | 4.26895051 |
| 25 | membrane disassembly (GO:0030397) | 4.16760589 |
| 26 | nuclear envelope disassembly (GO:0051081) | 4.16760589 |
| 27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.10121371 |
| 28 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 4.03294879 |
| 29 | regulation of mitotic spindle organization (GO:0060236) | 4.01256936 |
| 30 | metaphase plate congression (GO:0051310) | 3.91057852 |
| 31 | telomere maintenance via recombination (GO:0000722) | 3.84001750 |
| 32 | IMP metabolic process (GO:0046040) | 3.83452274 |
| 33 | regulation of spindle organization (GO:0090224) | 3.82808024 |
| 34 | DNA packaging (GO:0006323) | 3.81432701 |
| 35 | mitotic recombination (GO:0006312) | 3.80050637 |
| 36 | regulation of translational fidelity (GO:0006450) | 3.77292354 |
| 37 | regulation of RNA export from nucleus (GO:0046831) | 3.75783512 |
| 38 | positive regulation of chromosome segregation (GO:0051984) | 3.75245201 |
| 39 | IMP biosynthetic process (GO:0006188) | 3.73478581 |
| 40 | positive regulation of B cell differentiation (GO:0045579) | 3.71946270 |
| 41 | meiotic chromosome segregation (GO:0045132) | 3.70421977 |
| 42 | kinetochore organization (GO:0051383) | 3.67513037 |
| 43 | regulation of histone H3-K9 methylation (GO:0051570) | 3.59398946 |
| 44 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.58587195 |
| 45 | chromosome segregation (GO:0007059) | 3.56621032 |
| 46 | regulation of chromosome segregation (GO:0051983) | 3.56330668 |
| 47 | DNA conformation change (GO:0071103) | 3.55895748 |
| 48 | cytidine deamination (GO:0009972) | 3.54148873 |
| 49 | cytidine metabolic process (GO:0046087) | 3.54148873 |
| 50 | cytidine catabolic process (GO:0006216) | 3.54148873 |
| 51 | establishment of chromosome localization (GO:0051303) | 3.52292279 |
| 52 | DNA duplex unwinding (GO:0032508) | 3.52245349 |
| 53 | DNA synthesis involved in DNA repair (GO:0000731) | 3.48689608 |
| 54 | negative regulation of histone methylation (GO:0031061) | 3.48034088 |
| 55 | B cell receptor signaling pathway (GO:0050853) | 3.46790891 |
| 56 | formation of translation preinitiation complex (GO:0001731) | 3.46125845 |
| 57 | NIK/NF-kappaB signaling (GO:0038061) | 3.41949248 |
| 58 | negative regulation of chromosome segregation (GO:0051985) | 3.41304256 |
| 59 | DNA geometric change (GO:0032392) | 3.39723093 |
| 60 | CENP-A containing nucleosome assembly (GO:0034080) | 3.39242492 |
| 61 | actin-myosin filament sliding (GO:0033275) | 3.37948960 |
| 62 | muscle filament sliding (GO:0030049) | 3.37948960 |
| 63 | protein localization to chromosome (GO:0034502) | 3.37575692 |
| 64 | DNA ligation (GO:0006266) | 3.35228093 |
| 65 | nuclear envelope organization (GO:0006998) | 3.33567748 |
| 66 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.32369997 |
| 67 | chromatin remodeling at centromere (GO:0031055) | 3.32204690 |
| 68 | spindle checkpoint (GO:0031577) | 3.31338509 |
| 69 | positive regulation of antigen processing and presentation (GO:0002579) | 3.28611980 |
| 70 | establishment of integrated proviral latency (GO:0075713) | 3.28448558 |
| 71 | regulation of sister chromatid cohesion (GO:0007063) | 3.28132605 |
| 72 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.26683674 |
| 73 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.26683674 |
| 74 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.26683674 |
| 75 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.26683674 |
| 76 | negative regulation of sister chromatid segregation (GO:0033046) | 3.26683674 |
| 77 | mitotic spindle checkpoint (GO:0071174) | 3.22900900 |
| 78 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.22732074 |
| 79 | mitotic spindle assembly checkpoint (GO:0007094) | 3.21352514 |
| 80 | heterochromatin organization (GO:0070828) | 3.20477357 |
| 81 | regulation of mitotic sister chromatid separation (GO:0010965) | 3.18354029 |
| 82 | regulation of mitotic sister chromatid segregation (GO:0033047) | 3.18354029 |
| 83 | regulation of sister chromatid segregation (GO:0033045) | 3.18354029 |
| 84 | spindle assembly checkpoint (GO:0071173) | 3.17657241 |
| 85 | DNA replication-independent nucleosome organization (GO:0034724) | 3.15924061 |
| 86 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.15924061 |
| 87 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.15113080 |
| 88 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.15113080 |
| 89 | chromatin assembly or disassembly (GO:0006333) | 3.12655377 |
| 90 | regulation of centriole replication (GO:0046599) | 3.12268755 |
| 91 | regulation of superoxide anion generation (GO:0032928) | 3.10960360 |
| 92 | regulation of B cell differentiation (GO:0045577) | 3.09639863 |
| 93 | valine metabolic process (GO:0006573) | 3.09513126 |
| 94 | regulation of gamma-delta T cell activation (GO:0046643) | 3.08529233 |
| 95 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.08161080 |
| 96 | regulation of centrosome cycle (GO:0046605) | 3.06970024 |
| 97 | regulation of histone H3-K4 methylation (GO:0051569) | 3.04861901 |
| 98 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.03832537 |
| 99 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.03832537 |
| 100 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.03832537 |
| 101 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.03714960 |
| 102 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.03714960 |
| 103 | non-recombinational repair (GO:0000726) | 3.03550142 |
| 104 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.03550142 |
| 105 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.99298363 |
| 106 | microtubule depolymerization (GO:0007019) | 2.98091117 |
| 107 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.96822794 |
| 108 | telomere maintenance via telomere lengthening (GO:0010833) | 2.96765904 |
| 109 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.94781585 |
| 110 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.94653087 |
| 111 | regulation of DNA endoreduplication (GO:0032875) | 2.93395754 |
| 112 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 2.92011529 |
| 113 | peptide catabolic process (GO:0043171) | 2.91260085 |
| 114 | protein complex localization (GO:0031503) | 2.90114943 |
| 115 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 2.88886020 |
| 116 | chromatin assembly (GO:0031497) | 2.88120771 |
| 117 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.86951661 |
| 118 | purine nucleobase biosynthetic process (GO:0009113) | 2.83991956 |
| 119 | immunoglobulin mediated immune response (GO:0016064) | 2.83192418 |
| 120 | histone exchange (GO:0043486) | 2.81619073 |
| 121 | ATP-dependent chromatin remodeling (GO:0043044) | 2.81125065 |
| 122 | mitotic cell cycle (GO:0000278) | 2.80707913 |
| 123 | negative regulation of phagocytosis (GO:0050765) | 2.80130041 |
| 124 | neutrophil activation involved in immune response (GO:0002283) | 2.76359438 |
| 125 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.75066821 |
| 126 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.74272776 |
| 127 | cellular response to zinc ion (GO:0071294) | 2.72465331 |
| 128 | myeloid dendritic cell activation (GO:0001773) | 2.71661367 |
| 129 | dendritic cell chemotaxis (GO:0002407) | 2.69561515 |
| 130 | regulation of antigen processing and presentation (GO:0002577) | 2.69257441 |
| 131 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.67878905 |
| 132 | pentose-phosphate shunt (GO:0006098) | 2.67819448 |
| 133 | drug transmembrane transport (GO:0006855) | 2.67697986 |
| 134 | cysteine metabolic process (GO:0006534) | 2.67408560 |
| 135 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.66491763 |
| 136 | regulation of respiratory burst (GO:0060263) | 2.66423154 |
| 137 | neutrophil activation (GO:0042119) | 2.65529977 |
| 138 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.62551391 |
| 139 | cellular extravasation (GO:0045123) | 2.52724962 |
| 140 | leukotriene biosynthetic process (GO:0019370) | 2.52140844 |
| 141 | urea cycle (GO:0000050) | 2.50703541 |
| 142 | urea metabolic process (GO:0019627) | 2.50703541 |
| 143 | mannose metabolic process (GO:0006013) | 2.49399849 |
| 144 | ribosomal small subunit assembly (GO:0000028) | 2.47514910 |
| 145 | positive regulation of interferon-alpha production (GO:0032727) | 2.46732582 |
| 146 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.46015477 |
| 147 | indole-containing compound catabolic process (GO:0042436) | 2.44238371 |
| 148 | indolalkylamine catabolic process (GO:0046218) | 2.44238371 |
| 149 | tryptophan catabolic process (GO:0006569) | 2.44238371 |
| 150 | respiratory burst (GO:0045730) | 2.43143114 |
| 151 | regulation of interferon-alpha production (GO:0032647) | 2.42652507 |
| 152 | dendritic cell migration (GO:0036336) | 2.42598609 |
| 153 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.41566761 |
| 154 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.41469127 |
| 155 | cellular response to exogenous dsRNA (GO:0071360) | 2.41181738 |
| 156 | granulocyte activation (GO:0036230) | 2.40678857 |
| 157 | drug transport (GO:0015893) | 2.39587271 |
| 158 | myeloid dendritic cell differentiation (GO:0043011) | 2.39393873 |
| 159 | serine transport (GO:0032329) | 2.39270384 |
| 160 | regulation of lipoprotein particle clearance (GO:0010984) | 2.38695375 |
| 161 | L-phenylalanine metabolic process (GO:0006558) | 2.36841670 |
| 162 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.36841670 |
| 163 | B cell mediated immunity (GO:0019724) | 2.36728397 |
| 164 | negative regulation of B cell proliferation (GO:0030889) | 2.35942604 |
| 165 | NADPH regeneration (GO:0006740) | 2.33772101 |
| 166 | aromatic amino acid family catabolic process (GO:0009074) | 2.32232108 |
| 167 | sulfur amino acid catabolic process (GO:0000098) | 2.31649781 |
| 168 | leukotriene metabolic process (GO:0006691) | 2.29952337 |
| 169 | intestinal cholesterol absorption (GO:0030299) | 2.29057829 |
| 170 | pinocytosis (GO:0006907) | 2.28976448 |
| 171 | regulation of superoxide metabolic process (GO:0090322) | 2.28141206 |
| 172 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.27901194 |
| 173 | response to protozoan (GO:0001562) | 2.27824997 |
| 174 | tryptophan metabolic process (GO:0006568) | 2.27579310 |
| 175 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.26774582 |
| 176 | L-phenylalanine catabolic process (GO:0006559) | 2.26774582 |
| 177 | complement activation, classical pathway (GO:0006958) | 2.26525467 |
| 178 | dendritic cell differentiation (GO:0097028) | 2.24559342 |
| 179 | nitrogen cycle metabolic process (GO:0071941) | 2.24335314 |
| 180 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.24179389 |
| 181 | germinal center formation (GO:0002467) | 2.23363242 |
| 182 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.22611764 |
| 183 | regulation of B cell apoptotic process (GO:0002902) | 2.22332807 |
| 184 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.21592738 |
| 185 | homocysteine metabolic process (GO:0050667) | 2.20934841 |
| 186 | response to type I interferon (GO:0034340) | 2.20924664 |
| 187 | urate metabolic process (GO:0046415) | 2.20510323 |
| 188 | positive thymic T cell selection (GO:0045059) | 2.20184413 |
| 189 | tolerance induction (GO:0002507) | 2.19690740 |
| 190 | hypotonic response (GO:0006971) | 2.19297564 |
| 191 | response to nitrosative stress (GO:0051409) | 2.17210752 |
| 192 | positive regulation of respiratory burst (GO:0060267) | 2.16169029 |
| 193 | regulation of B cell proliferation (GO:0030888) | 2.15613251 |
| 194 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.14610489 |
| 195 | natural killer cell mediated immunity (GO:0002228) | 2.13661491 |
| 196 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.13661491 |
| 197 | regulation of RIG-I signaling pathway (GO:0039535) | 2.13267919 |
| 198 | cellular modified amino acid catabolic process (GO:0042219) | 2.13198254 |
| 199 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.12977219 |
| 200 | type I interferon signaling pathway (GO:0060337) | 2.12942014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.24673578 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.89968813 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.60993110 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.22286686 |
| 5 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.12451357 |
| 6 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 3.07019805 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.95895427 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.79142706 |
| 9 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.77469012 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.63331710 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.62975590 |
| 12 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.59819351 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.58621806 |
| 14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.57157945 |
| 15 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.54121657 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.52716297 |
| 17 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.51764832 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.50950764 |
| 19 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.44791843 |
| 20 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.39107852 |
| 21 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.36530133 |
| 22 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.35386839 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 2.31998844 |
| 24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.30178511 |
| 25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.28948819 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.24251252 |
| 27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.21425864 |
| 28 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.19682844 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.16680880 |
| 30 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.16161377 |
| 31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.14476942 |
| 32 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.13207845 |
| 33 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.07178109 |
| 34 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 2.06107300 |
| 35 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06051893 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.99945843 |
| 37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.99476031 |
| 38 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.99136418 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.95306375 |
| 40 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.94787745 |
| 41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.91179861 |
| 42 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.90551851 |
| 43 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.89145557 |
| 44 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.88661032 |
| 45 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.86721043 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86649344 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.85690553 |
| 48 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.85183854 |
| 49 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.84656798 |
| 50 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.83338907 |
| 51 | MYB_26560356_Chip-Seq_TH2_Human | 1.83270368 |
| 52 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.81855043 |
| 53 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79455773 |
| 54 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.78680323 |
| 55 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.78507408 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.76652302 |
| 57 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.75575512 |
| 58 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.75195167 |
| 59 | MYB_26560356_Chip-Seq_TH1_Human | 1.74375664 |
| 60 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.73565710 |
| 61 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.72498640 |
| 62 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.72480386 |
| 63 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.70144362 |
| 64 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.69082739 |
| 65 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68925427 |
| 66 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.66819813 |
| 67 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.64129234 |
| 68 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.63415682 |
| 69 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.62754026 |
| 70 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62185572 |
| 71 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.57901378 |
| 72 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.57633629 |
| 73 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.57192241 |
| 74 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.55735115 |
| 75 | UTX_26944678_Chip-Seq_JUKART_Human | 1.55270221 |
| 76 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.54223753 |
| 77 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.52970562 |
| 78 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.49431708 |
| 79 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.48149915 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.46651406 |
| 81 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.45257210 |
| 82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.43780148 |
| 83 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.42294144 |
| 84 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.40728665 |
| 85 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.39147615 |
| 86 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.38419076 |
| 87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38394878 |
| 88 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.35897437 |
| 89 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.35000446 |
| 90 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34802501 |
| 91 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.34270868 |
| 92 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.33881659 |
| 93 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.33586752 |
| 94 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.33314398 |
| 95 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.33265442 |
| 96 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.32883745 |
| 97 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32440273 |
| 98 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.30462133 |
| 99 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.30449288 |
| 100 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28229358 |
| 101 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.26977494 |
| 102 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.24546827 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23968673 |
| 104 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.22364192 |
| 105 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.19901147 |
| 106 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.18388618 |
| 107 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18210104 |
| 108 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.17709333 |
| 109 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.17498899 |
| 110 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.17092845 |
| 111 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.16605455 |
| 112 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.16290763 |
| 113 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.15865018 |
| 114 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.15828930 |
| 115 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.14900143 |
| 116 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14725248 |
| 117 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12861812 |
| 118 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12173619 |
| 119 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11202782 |
| 120 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.10694757 |
| 121 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.10489536 |
| 122 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.10376036 |
| 123 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.10138495 |
| 124 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.10049561 |
| 125 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.08511202 |
| 126 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.08027849 |
| 127 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07428896 |
| 128 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07104275 |
| 129 | MAF_26560356_Chip-Seq_TH2_Human | 1.05840089 |
| 130 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.04019723 |
| 131 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03773620 |
| 132 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.03575031 |
| 133 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.03329221 |
| 134 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.02725966 |
| 135 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.02577246 |
| 136 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02082976 |
| 137 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01926734 |
| 138 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.98539432 |
| 139 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98258209 |
| 140 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97089053 |
| 141 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96595894 |
| 142 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.96449453 |
| 143 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.95808047 |
| 144 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.95608246 |
| 145 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.94932173 |
| 146 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94655872 |
| 147 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.94493145 |
| 148 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.94394527 |
| 149 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.93958523 |
| 150 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.93599834 |
| 151 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93066931 |
| 152 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.91826394 |
| 153 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91230306 |
| 154 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.90894872 |
| 155 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.90860472 |
| 156 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.90508368 |
| 157 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.90122969 |
| 158 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.89450242 |
| 159 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88368966 |
| 160 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87995086 |
| 161 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87733381 |
| 162 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87324489 |
| 163 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.87146366 |
| 164 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79395134 |
| 165 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.78077137 |
| 166 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.75967959 |
| 167 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.75447324 |
| 168 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.75265592 |
| 169 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.75253026 |
| 170 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.74509173 |
| 171 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.74482504 |
| 172 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.74337451 |
| 173 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.73530299 |
| 174 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.72643979 |
| 175 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.70683926 |
| 176 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.70115646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 4.40076335 |
| 2 | MP0003111_abnormal_nucleus_morphology | 4.34492286 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.52006089 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 3.50484377 |
| 5 | MP0003077_abnormal_cell_cycle | 3.43542147 |
| 6 | MP0008058_abnormal_DNA_repair | 3.17731014 |
| 7 | MP0003300_gastrointestinal_ulcer | 3.13928204 |
| 8 | MP0000685_abnormal_immune_system | 2.79072925 |
| 9 | MP0003646_muscle_fatigue | 2.77794465 |
| 10 | MP0004145_abnormal_muscle_electrophysio | 2.69865901 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.68929048 |
| 12 | MP0005451_abnormal_body_composition | 2.60599795 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.60313580 |
| 14 | MP0000749_muscle_degeneration | 2.56058193 |
| 15 | MP0000751_myopathy | 2.55588770 |
| 16 | MP0005360_urolithiasis | 2.54158663 |
| 17 | MP0008932_abnormal_embryonic_tissue | 2.47908234 |
| 18 | MP0004233_abnormal_muscle_weight | 2.43540176 |
| 19 | MP0001873_stomach_inflammation | 2.39031344 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.38313861 |
| 21 | MP0005387_immune_system_phenotype | 2.37458972 |
| 22 | MP0001790_abnormal_immune_system | 2.37458972 |
| 23 | MP0001800_abnormal_humoral_immune | 2.34782703 |
| 24 | MP0001730_embryonic_growth_arrest | 2.26850734 |
| 25 | MP0010155_abnormal_intestine_physiology | 2.08968291 |
| 26 | MP0002269_muscular_atrophy | 2.04874897 |
| 27 | MP0009697_abnormal_copulation | 1.99397811 |
| 28 | MP0008007_abnormal_cellular_replicative | 1.98601426 |
| 29 | MP0002254_reproductive_system_inflammat | 1.97231617 |
| 30 | MP0001666_abnormal_nutrient_absorption | 1.96240061 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.95104176 |
| 32 | MP0003436_decreased_susceptibility_to | 1.93864967 |
| 33 | MP0003718_maternal_effect | 1.93370991 |
| 34 | MP0004036_abnormal_muscle_relaxation | 1.91951869 |
| 35 | MP0002396_abnormal_hematopoietic_system | 1.90736872 |
| 36 | MP0009785_altered_susceptibility_to | 1.90318223 |
| 37 | MP0005365_abnormal_bile_salt | 1.89831209 |
| 38 | MP0000350_abnormal_cell_proliferation | 1.89522708 |
| 39 | MP0005025_abnormal_response_to | 1.89390814 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 1.85757954 |
| 41 | MP0004087_abnormal_muscle_fiber | 1.85217253 |
| 42 | MP0005085_abnormal_gallbladder_physiolo | 1.82863314 |
| 43 | MP0005671_abnormal_response_to | 1.82461806 |
| 44 | MP0000747_muscle_weakness | 1.82210791 |
| 45 | MP0005000_abnormal_immune_tolerance | 1.80760192 |
| 46 | MP0005310_abnormal_salivary_gland | 1.79443253 |
| 47 | MP0005380_embryogenesis_phenotype | 1.75870057 |
| 48 | MP0001672_abnormal_embryogenesis/_devel | 1.75870057 |
| 49 | MP0002006_tumorigenesis | 1.73758739 |
| 50 | MP0002723_abnormal_immune_serum | 1.73376541 |
| 51 | MP0001853_heart_inflammation | 1.70752893 |
| 52 | MP0002106_abnormal_muscle_physiology | 1.68202968 |
| 53 | MP0000759_abnormal_skeletal_muscle | 1.67702526 |
| 54 | MP0004084_abnormal_cardiac_muscle | 1.67595971 |
| 55 | MP0002148_abnormal_hypersensitivity_rea | 1.67431870 |
| 56 | MP0002420_abnormal_adaptive_immunity | 1.66799852 |
| 57 | MP0009672_abnormal_birth_weight | 1.65599826 |
| 58 | MP0001819_abnormal_immune_cell | 1.64931103 |
| 59 | MP0003866_abnormal_defecation | 1.64651489 |
| 60 | MP0001697_abnormal_embryo_size | 1.63140470 |
| 61 | MP0002419_abnormal_innate_immunity | 1.62613846 |
| 62 | MP0003303_peritoneal_inflammation | 1.62514934 |
| 63 | MP0004147_increased_porphyrin_level | 1.61954751 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.59578281 |
| 65 | MP0003984_embryonic_growth_retardation | 1.57713230 |
| 66 | MP0005330_cardiomyopathy | 1.57405534 |
| 67 | MP0001845_abnormal_inflammatory_respons | 1.55823588 |
| 68 | MP0002080_prenatal_lethality | 1.54487360 |
| 69 | MP0003763_abnormal_thymus_physiology | 1.53829029 |
| 70 | MP0000490_abnormal_crypts_of | 1.53707339 |
| 71 | MP0002088_abnormal_embryonic_growth/wei | 1.51049345 |
| 72 | MP0009643_abnormal_urine_homeostasis | 1.50920750 |
| 73 | MP0003252_abnormal_bile_duct | 1.50194940 |
| 74 | MP0003221_abnormal_cardiomyocyte_apopto | 1.49013106 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 1.48796040 |
| 76 | MP0004264_abnormal_extraembryonic_tissu | 1.47784215 |
| 77 | MP0002398_abnormal_bone_marrow | 1.47640947 |
| 78 | MP0000716_abnormal_immune_system | 1.44272107 |
| 79 | MP0004947_skin_inflammation | 1.42377970 |
| 80 | MP0008875_abnormal_xenobiotic_pharmacok | 1.41751126 |
| 81 | MP0001661_extended_life_span | 1.39848398 |
| 82 | MP0010630_abnormal_cardiac_muscle | 1.38919779 |
| 83 | MP0003786_premature_aging | 1.38685061 |
| 84 | MP0006036_abnormal_mitochondrial_physio | 1.38517673 |
| 85 | MP0000689_abnormal_spleen_morphology | 1.35949499 |
| 86 | MP0000313_abnormal_cell_death | 1.35800777 |
| 87 | MP0005369_muscle_phenotype | 1.30359235 |
| 88 | MP0002085_abnormal_embryonic_tissue | 1.29678458 |
| 89 | MP0003183_abnormal_peptide_metabolism | 1.29497643 |
| 90 | MP0002405_respiratory_system_inflammati | 1.29184172 |
| 91 | MP0006035_abnormal_mitochondrial_morpho | 1.28895476 |
| 92 | MP0002722_abnormal_immune_system | 1.26829479 |
| 93 | MP0003191_abnormal_cellular_cholesterol | 1.26545515 |
| 94 | MP0002084_abnormal_developmental_patter | 1.26272959 |
| 95 | MP0004197_abnormal_fetal_growth/weight/ | 1.25379823 |
| 96 | MP0002136_abnormal_kidney_physiology | 1.25346540 |
| 97 | MP0008469_abnormal_protein_level | 1.24898159 |
| 98 | MP0003890_abnormal_embryonic-extraembry | 1.23966112 |
| 99 | MP0005464_abnormal_platelet_physiology | 1.23845629 |
| 100 | MP0008995_early_reproductive_senescence | 1.23574176 |
| 101 | MP0002429_abnormal_blood_cell | 1.23465896 |
| 102 | MP0009764_decreased_sensitivity_to | 1.20995476 |
| 103 | MP0009840_abnormal_foam_cell | 1.20310507 |
| 104 | MP0005332_abnormal_amino_acid | 1.20293038 |
| 105 | MP0005083_abnormal_biliary_tract | 1.16874957 |
| 106 | MP0002928_abnormal_bile_duct | 1.15835463 |
| 107 | MP0002086_abnormal_extraembryonic_tissu | 1.15520905 |
| 108 | MP0005058_abnormal_lysosome_morphology | 1.15112688 |
| 109 | MP0009333_abnormal_splenocyte_physiolog | 1.15001452 |
| 110 | MP0000609_abnormal_liver_physiology | 1.14767066 |
| 111 | MP0010352_gastrointestinal_tract_polyps | 1.12188302 |
| 112 | MP0000750_abnormal_muscle_regeneration | 1.10323908 |
| 113 | MP0004019_abnormal_vitamin_homeostasis | 1.09918057 |
| 114 | MP0002876_abnormal_thyroid_physiology | 1.09482728 |
| 115 | MP0001663_abnormal_digestive_system | 1.09047872 |
| 116 | MP0002210_abnormal_sex_determination | 1.08984202 |
| 117 | MP0001929_abnormal_gametogenesis | 1.08973835 |
| 118 | MP0000733_abnormal_muscle_development | 1.07061336 |
| 119 | MP0003453_abnormal_keratinocyte_physiol | 1.06770286 |
| 120 | MP0003567_abnormal_fetal_cardiomyocyte | 1.06075154 |
| 121 | MP0000858_altered_metastatic_potential | 1.05897953 |
| 122 | MP0004808_abnormal_hematopoietic_stem | 1.05458641 |
| 123 | MP0005220_abnormal_exocrine_pancreas | 1.05133385 |
| 124 | MP0006082_CNS_inflammation | 1.04862488 |
| 125 | MP0009703_decreased_birth_body | 1.04166834 |
| 126 | MP0003693_abnormal_embryo_hatching | 1.04009788 |
| 127 | MP0009278_abnormal_bone_marrow | 1.02175865 |
| 128 | MP0003868_abnormal_feces_composition | 1.00859929 |
| 129 | MP0000465_gastrointestinal_hemorrhage | 1.00103672 |
| 130 | MP0006292_abnormal_olfactory_placode | 0.99882773 |
| 131 | MP0010329_abnormal_lipoprotein_level | 0.98338985 |
| 132 | MP0003705_abnormal_hypodermis_morpholog | 0.97802884 |
| 133 | MP0002009_preneoplasia | 0.97337835 |
| 134 | MP0005397_hematopoietic_system_phenotyp | 0.97061174 |
| 135 | MP0001545_abnormal_hematopoietic_system | 0.97061174 |
| 136 | MP0001764_abnormal_homeostasis | 0.95777119 |
| 137 | MP0005319_abnormal_enzyme/_coenzyme | 0.95713389 |
| 138 | MP0002877_abnormal_melanocyte_morpholog | 0.95188448 |
| 139 | MP0009763_increased_sensitivity_to | 0.94834830 |
| 140 | MP0002019_abnormal_tumor_incidence | 0.92396292 |
| 141 | MP0006054_spinal_hemorrhage | 0.92045357 |
| 142 | MP0010030_abnormal_orbit_morphology | 0.90740832 |
| 143 | MP0003724_increased_susceptibility_to | 0.88399276 |
| 144 | MP0000703_abnormal_thymus_morphology | 0.88350039 |
| 145 | MP0001765_abnormal_ion_homeostasis | 0.86489785 |
| 146 | MP0000358_abnormal_cell_content/ | 0.86026160 |
| 147 | MP0006138_congestive_heart_failure | 0.85579252 |
| 148 | MP0003186_abnormal_redox_activity | 0.85540058 |
| 149 | MP0005266_abnormal_metabolism | 0.84991836 |
| 150 | MP0004510_myositis | 0.84793683 |
| 151 | MP0001756_abnormal_urination | 0.84331028 |
| 152 | MP0000477_abnormal_intestine_morphology | 0.84184862 |
| 153 | MP0010307_abnormal_tumor_latency | 0.83525165 |
| 154 | MP0008877_abnormal_DNA_methylation | 0.83311162 |
| 155 | MP0005636_abnormal_mineral_homeostasis | 0.82952870 |
| 156 | MP0001533_abnormal_skeleton_physiology | 0.82161397 |
| 157 | MP0005620_abnormal_muscle_contractility | 0.82154727 |
| 158 | MP0009765_abnormal_xenobiotic_induced | 0.79991455 |
| 159 | MP0001145_abnormal_male_reproductive | 0.79792878 |
| 160 | MP0000598_abnormal_liver_morphology | 0.79754684 |
| 161 | MP0010094_abnormal_chromosome_stability | 0.79596495 |
| 162 | MP0002332_abnormal_exercise_endurance | 0.77566015 |
| 163 | MP0005381_digestive/alimentary_phenotyp | 0.76163999 |
| 164 | MP0001881_abnormal_mammary_gland | 0.75979690 |
| 165 | MP0003656_abnormal_erythrocyte_physiolo | 0.75872466 |
| 166 | MP0004215_abnormal_myocardial_fiber | 0.75735813 |
| 167 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75260896 |
| 168 | MP0001216_abnormal_epidermal_layer | 0.74523456 |
| 169 | MP0001346_abnormal_lacrimal_gland | 0.73056241 |
| 170 | MP0000678_abnormal_parathyroid_gland | 0.72890400 |
| 171 | MP0002972_abnormal_cardiac_muscle | 0.72808883 |
| 172 | MP0003699_abnormal_female_reproductive | 0.72664891 |
| 173 | MP0005666_abnormal_adipose_tissue | 0.72579265 |
| 174 | MP0005384_cellular_phenotype | 0.71567019 |
| 175 | MP0000653_abnormal_sex_gland | 0.71392466 |
| 176 | MP0005621_abnormal_cell_physiology | 0.71044972 |
| 177 | MP0001544_abnormal_cardiovascular_syste | 0.68727754 |
| 178 | MP0005385_cardiovascular_system_phenoty | 0.68727754 |
| 179 | MP0000266_abnormal_heart_morphology | 0.67503942 |
| 180 | MP0003698_abnormal_male_reproductive | 0.67061619 |
| 181 | MP0003937_abnormal_limbs/digits/tail_de | 0.66517780 |
| 182 | MP0000428_abnormal_craniofacial_morphol | 0.65992527 |
| 183 | MP0001293_anophthalmia | 0.65915903 |
| 184 | MP0003385_abnormal_body_wall | 0.65328214 |
| 185 | MP0002697_abnormal_eye_size | 0.64658726 |
| 186 | MP0002837_dystrophic_cardiac_calcinosis | 0.64323477 |
| 187 | MP0002161_abnormal_fertility/fecundity | 0.63713476 |
| 188 | MP0004130_abnormal_muscle_cell | 0.61433556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 5.80720803 |
| 2 | Nemaline bodies (HP:0003798) | 5.78767777 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.62878551 |
| 4 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.81282502 |
| 5 | Exercise-induced myalgia (HP:0003738) | 4.76865758 |
| 6 | Chromsome breakage (HP:0040012) | 4.63983038 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 4.60271855 |
| 8 | Agammaglobulinemia (HP:0004432) | 4.28445617 |
| 9 | Inflammation of the large intestine (HP:0002037) | 3.84587319 |
| 10 | Colitis (HP:0002583) | 3.81822436 |
| 11 | Gastrointestinal inflammation (HP:0004386) | 3.65851316 |
| 12 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.65796919 |
| 13 | Myopathic facies (HP:0002058) | 3.60718103 |
| 14 | Eczematoid dermatitis (HP:0000976) | 3.56868379 |
| 15 | Pustule (HP:0200039) | 3.54111151 |
| 16 | Abnormal gallbladder physiology (HP:0012438) | 3.48757129 |
| 17 | Cholecystitis (HP:0001082) | 3.48757129 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.48576076 |
| 19 | Recurrent viral infections (HP:0004429) | 3.43137405 |
| 20 | IgM deficiency (HP:0002850) | 3.41771548 |
| 21 | Cellulitis (HP:0100658) | 3.40571532 |
| 22 | Type 1 muscle fiber predominance (HP:0003803) | 3.40551443 |
| 23 | Recurrent fungal infections (HP:0002841) | 3.40056357 |
| 24 | Recurrent abscess formation (HP:0002722) | 3.34610532 |
| 25 | Progressive muscle weakness (HP:0003323) | 3.32587177 |
| 26 | Recurrent bronchitis (HP:0002837) | 3.21250498 |
| 27 | Thrombocytosis (HP:0001894) | 3.19764187 |
| 28 | Rimmed vacuoles (HP:0003805) | 3.17198476 |
| 29 | Gastrointestinal stroma tumor (HP:0100723) | 3.14515641 |
| 30 | B lymphocytopenia (HP:0010976) | 3.07999078 |
| 31 | Abnormality of B cell number (HP:0010975) | 3.07999078 |
| 32 | EMG: myopathic abnormalities (HP:0003458) | 3.01770052 |
| 33 | Birth length less than 3rd percentile (HP:0003561) | 3.00001476 |
| 34 | Meningitis (HP:0001287) | 2.99329159 |
| 35 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.95967975 |
| 36 | Recurrent cutaneous fungal infections (HP:0011370) | 2.95967975 |
| 37 | Myoglobinuria (HP:0002913) | 2.95561255 |
| 38 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.93015120 |
| 39 | Subaortic stenosis (HP:0001682) | 2.93015120 |
| 40 | Vacuolated lymphocytes (HP:0001922) | 2.91043020 |
| 41 | Calcaneovalgus deformity (HP:0001848) | 2.90369045 |
| 42 | Rhabdomyolysis (HP:0003201) | 2.88270283 |
| 43 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.87987864 |
| 44 | Recurrent sinusitis (HP:0011108) | 2.86894432 |
| 45 | Panhypogammaglobulinemia (HP:0003139) | 2.86693877 |
| 46 | Periodontitis (HP:0000704) | 2.85053492 |
| 47 | Recurrent skin infections (HP:0001581) | 2.83810419 |
| 48 | Interstitial pulmonary disease (HP:0006530) | 2.80826128 |
| 49 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.79816338 |
| 50 | Increased connective tissue (HP:0009025) | 2.78786737 |
| 51 | Verrucae (HP:0200043) | 2.77801765 |
| 52 | Papilloma (HP:0012740) | 2.77801765 |
| 53 | Progressive external ophthalmoplegia (HP:0000590) | 2.77329795 |
| 54 | Cortical dysplasia (HP:0002539) | 2.75995770 |
| 55 | Increased nuchal translucency (HP:0010880) | 2.75381346 |
| 56 | Osteomyelitis (HP:0002754) | 2.72183122 |
| 57 | Reticulocytosis (HP:0001923) | 2.70115608 |
| 58 | Abnormality of chromosome stability (HP:0003220) | 2.68692055 |
| 59 | Abnormality of reticulocytes (HP:0004312) | 2.65526132 |
| 60 | Abnormality of the calcaneus (HP:0008364) | 2.65203841 |
| 61 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.63897622 |
| 62 | Abnormality of the preputium (HP:0100587) | 2.62235441 |
| 63 | Poikiloderma (HP:0001029) | 2.61891024 |
| 64 | Abnormality of T cell physiology (HP:0011840) | 2.59133012 |
| 65 | Abnormality of the fingertips (HP:0001211) | 2.58909768 |
| 66 | IgA deficiency (HP:0002720) | 2.56315326 |
| 67 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.56248922 |
| 68 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.55478919 |
| 69 | Gout (HP:0001997) | 2.54157599 |
| 70 | Autoimmune thrombocytopenia (HP:0001973) | 2.49401625 |
| 71 | Chronic otitis media (HP:0000389) | 2.49047774 |
| 72 | Myelodysplasia (HP:0002863) | 2.47290075 |
| 73 | Lymphopenia (HP:0001888) | 2.45378366 |
| 74 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.45031661 |
| 75 | Distal arthrogryposis (HP:0005684) | 2.44506730 |
| 76 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.43221967 |
| 77 | Deformed tarsal bones (HP:0008119) | 2.42464227 |
| 78 | Meckel diverticulum (HP:0002245) | 2.39114669 |
| 79 | Vasculitis (HP:0002633) | 2.35940720 |
| 80 | Bowel incontinence (HP:0002607) | 2.34518647 |
| 81 | Shoulder girdle muscle weakness (HP:0003547) | 2.33438194 |
| 82 | Cholelithiasis (HP:0001081) | 2.33359710 |
| 83 | Muscle stiffness (HP:0003552) | 2.32823906 |
| 84 | Reticulocytopenia (HP:0001896) | 2.32587458 |
| 85 | Myositis (HP:0100614) | 2.32537572 |
| 86 | Duodenal stenosis (HP:0100867) | 2.31763671 |
| 87 | Small intestinal stenosis (HP:0012848) | 2.31763671 |
| 88 | Abnormality of the ileum (HP:0001549) | 2.28700962 |
| 89 | Nasal polyposis (HP:0100582) | 2.27744412 |
| 90 | Recurrent pneumonia (HP:0006532) | 2.27177109 |
| 91 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.26684071 |
| 92 | Ragged-red muscle fibers (HP:0003200) | 2.26634403 |
| 93 | Abnormality of purine metabolism (HP:0004352) | 2.26577982 |
| 94 | Abnormal large intestine physiology (HP:0012700) | 2.26171518 |
| 95 | Microvesicular hepatic steatosis (HP:0001414) | 2.25176114 |
| 96 | Cafe-au-lait spot (HP:0000957) | 2.24920413 |
| 97 | Truncus arteriosus (HP:0001660) | 2.23352925 |
| 98 | Long clavicles (HP:0000890) | 2.22856171 |
| 99 | Calf muscle hypertrophy (HP:0008981) | 2.21987559 |
| 100 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.21760335 |
| 101 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.21737238 |
| 102 | Mediastinal lymphadenopathy (HP:0100721) | 2.19865829 |
| 103 | Neck muscle weakness (HP:0000467) | 2.18406961 |
| 104 | Cheilitis (HP:0100825) | 2.18171302 |
| 105 | Difficulty running (HP:0009046) | 2.17938267 |
| 106 | Gingivitis (HP:0000230) | 2.17147661 |
| 107 | Pelvic girdle muscle weakness (HP:0003749) | 2.16699573 |
| 108 | Abnormality of nucleobase metabolism (HP:0010932) | 2.16123147 |
| 109 | Abnormality of T cells (HP:0002843) | 2.16040548 |
| 110 | Muscle fiber splitting (HP:0003555) | 2.16019566 |
| 111 | Thyroiditis (HP:0100646) | 2.14896171 |
| 112 | Abnormality of the gastric mucosa (HP:0004295) | 2.12402934 |
| 113 | Dysmetric saccades (HP:0000641) | 2.10843947 |
| 114 | Hypoplasia of the thymus (HP:0000778) | 2.10729001 |
| 115 | Abnormality of chloride homeostasis (HP:0011422) | 2.09688575 |
| 116 | Abnormal lung lobation (HP:0002101) | 2.09665880 |
| 117 | Chronic diarrhea (HP:0002028) | 2.09128097 |
| 118 | Dehydration (HP:0001944) | 2.08588729 |
| 119 | Distal lower limb amyotrophy (HP:0008944) | 2.08554601 |
| 120 | Abnormality of cochlea (HP:0000375) | 2.08248725 |
| 121 | Embryonal renal neoplasm (HP:0011794) | 2.06815290 |
| 122 | Recurrent lower respiratory tract infections (HP:0002783) | 2.06329192 |
| 123 | Hyporeflexia of lower limbs (HP:0002600) | 2.06247447 |
| 124 | Multiple enchondromatosis (HP:0005701) | 2.04863789 |
| 125 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.04726243 |
| 126 | Encephalitis (HP:0002383) | 2.04456915 |
| 127 | Urticaria (HP:0001025) | 2.03092190 |
| 128 | IgG deficiency (HP:0004315) | 2.02842614 |
| 129 | Emphysema (HP:0002097) | 2.01533225 |
| 130 | Skin ulcer (HP:0200042) | 2.01348183 |
| 131 | Abnormal gallbladder morphology (HP:0012437) | 2.01296469 |
| 132 | Sepsis (HP:0100806) | 2.00853376 |
| 133 | Impaired platelet aggregation (HP:0003540) | 1.99940140 |
| 134 | Abnormal platelet function (HP:0011869) | 1.99940140 |
| 135 | Abnormality of the calf musculature (HP:0001430) | 1.99161315 |
| 136 | Abnormality of proline metabolism (HP:0010907) | 1.98861807 |
| 137 | Hydroxyprolinuria (HP:0003080) | 1.98861807 |
| 138 | Gingival bleeding (HP:0000225) | 1.98665204 |
| 139 | Overlapping toe (HP:0001845) | 1.98580218 |
| 140 | Abnormality of glycolysis (HP:0004366) | 1.98426676 |
| 141 | Ectopic kidney (HP:0000086) | 1.98392941 |
| 142 | Spontaneous hematomas (HP:0007420) | 1.96941488 |
| 143 | Hyperglycinuria (HP:0003108) | 1.96176590 |
| 144 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.95213475 |
| 145 | Hyperuricemia (HP:0002149) | 1.94709371 |
| 146 | Increased purine levels (HP:0004368) | 1.94709371 |
| 147 | Sudden death (HP:0001699) | 1.94643548 |
| 148 | EMG: neuropathic changes (HP:0003445) | 1.91508616 |
| 149 | Ankyloglossia (HP:0010296) | 1.90915604 |
| 150 | Villous atrophy (HP:0011473) | 1.90606373 |
| 151 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.90606373 |
| 152 | Abnormality of macrophages (HP:0004311) | 1.89581012 |
| 153 | Eosinophilia (HP:0001880) | 1.89443431 |
| 154 | Restrictive lung disease (HP:0002091) | 1.88568685 |
| 155 | Viral hepatitis (HP:0006562) | 1.88158242 |
| 156 | Bronchitis (HP:0012387) | 1.87869223 |
| 157 | Systemic lupus erythematosus (HP:0002725) | 1.87329567 |
| 158 | Micronodular cirrhosis (HP:0001413) | 1.87235767 |
| 159 | Acute myeloid leukemia (HP:0004808) | 1.86407570 |
| 160 | Abnormality of T cell number (HP:0011839) | 1.85478553 |
| 161 | Ependymoma (HP:0002888) | 1.84359869 |
| 162 | Abnormality of the duodenum (HP:0002246) | 1.83850326 |
| 163 | Ulnar deviation of the wrist (HP:0003049) | 1.83576778 |
| 164 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.83571359 |
| 165 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.83571359 |
| 166 | Abnormality of the nasal mucosa (HP:0000433) | 1.82351133 |
| 167 | Duplicated collecting system (HP:0000081) | 1.81702929 |
| 168 | Volvulus (HP:0002580) | 1.81471015 |
| 169 | Abnormality of the carotid arteries (HP:0005344) | 1.81430991 |
| 170 | Intrahepatic cholestasis (HP:0001406) | 1.80508751 |
| 171 | Neutropenia (HP:0001875) | 1.80367265 |
| 172 | Fat malabsorption (HP:0002630) | 1.80338464 |
| 173 | Premature loss of primary teeth (HP:0006323) | 1.79957747 |
| 174 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.79575755 |
| 175 | Mucopolysacchariduria (HP:0008155) | 1.79575755 |
| 176 | Esophageal varix (HP:0002040) | 1.78589462 |
| 177 | T lymphocytopenia (HP:0005403) | 1.78539556 |
| 178 | Joint hemorrhage (HP:0005261) | 1.77302353 |
| 179 | Abnormal foot bone ossification (HP:0010675) | 1.77207920 |
| 180 | Keratoconjunctivitis (HP:0001096) | 1.77184282 |
| 181 | Increased serum pyruvate (HP:0003542) | 1.73759855 |
| 182 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 1.72649803 |
| 183 | Abnormality of homocysteine metabolism (HP:0010919) | 1.72441076 |
| 184 | Homocystinuria (HP:0002156) | 1.72441076 |
| 185 | Increased variability in muscle fiber diameter (HP:0003557) | 1.69052541 |
| 186 | Areflexia of lower limbs (HP:0002522) | 1.65938635 |
| 187 | Sandal gap (HP:0001852) | 1.65161198 |
| 188 | Abnormality of the salivary glands (HP:0010286) | 1.65104556 |
| 189 | Abnormality of DNA repair (HP:0003254) | 1.64226641 |
| 190 | Rhabdomyosarcoma (HP:0002859) | 1.64150372 |
| 191 | Sloping forehead (HP:0000340) | 1.63454880 |
| 192 | High anterior hairline (HP:0009890) | 1.63115566 |
| 193 | Distal lower limb muscle weakness (HP:0009053) | 1.62887065 |
| 194 | Abnormality of the tricuspid valve (HP:0001702) | 1.62702056 |
| 195 | Facial hemangioma (HP:0000329) | 1.62609413 |
| 196 | Absent radius (HP:0003974) | 1.61900758 |
| 197 | Narrow face (HP:0000275) | 1.61830871 |
| 198 | Dilated cardiomyopathy (HP:0001644) | 1.61544756 |
| 199 | Abnormality of chromosome segregation (HP:0002916) | 1.60901682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.20171489 |
| 2 | BUB1 | 4.01282627 |
| 3 | CDC7 | 3.99955797 |
| 4 | OBSCN | 3.81353238 |
| 5 | TTK | 3.80638854 |
| 6 | MAP4K1 | 3.48053643 |
| 7 | EPHA2 | 2.82189597 |
| 8 | TTN | 2.71000982 |
| 9 | TAOK3 | 2.65123412 |
| 10 | MAP3K14 | 2.61184452 |
| 11 | MAP3K10 | 2.42749033 |
| 12 | CCNB1 | 2.41160847 |
| 13 | MST4 | 2.39761776 |
| 14 | PLK4 | 2.39105060 |
| 15 | NEK1 | 2.37891315 |
| 16 | SRPK1 | 2.36341999 |
| 17 | WEE1 | 2.21235839 |
| 18 | PBK | 2.20027945 |
| 19 | IRAK3 | 2.13654857 |
| 20 | IRAK4 | 2.07245818 |
| 21 | TYK2 | 1.98851857 |
| 22 | STK10 | 1.96620318 |
| 23 | FRK | 1.92339596 |
| 24 | BTK | 1.89510571 |
| 25 | TBK1 | 1.88025964 |
| 26 | ICK | 1.87954627 |
| 27 | KSR2 | 1.82002228 |
| 28 | GRK6 | 1.79871459 |
| 29 | BCKDK | 1.71658628 |
| 30 | BLK | 1.69947204 |
| 31 | CSF1R | 1.66507697 |
| 32 | TSSK6 | 1.65552478 |
| 33 | TEC | 1.62823618 |
| 34 | EIF2AK3 | 1.61372112 |
| 35 | BRSK2 | 1.59996405 |
| 36 | CHEK2 | 1.59574899 |
| 37 | CDK12 | 1.58456133 |
| 38 | PLK1 | 1.57247394 |
| 39 | EEF2K | 1.53945950 |
| 40 | LRRK2 | 1.48338851 |
| 41 | JAK3 | 1.44924849 |
| 42 | IKBKE | 1.44791671 |
| 43 | NME1 | 1.43213381 |
| 44 | PHKG2 | 1.41908662 |
| 45 | PHKG1 | 1.41908662 |
| 46 | CHEK1 | 1.41247210 |
| 47 | FGFR4 | 1.40436761 |
| 48 | FLT3 | 1.40194230 |
| 49 | KIT | 1.40060289 |
| 50 | ZAP70 | 1.39555730 |
| 51 | PTK6 | 1.38966382 |
| 52 | PRPF4B | 1.35477082 |
| 53 | RPS6KB2 | 1.34422590 |
| 54 | BRSK1 | 1.31982708 |
| 55 | RAF1 | 1.30875542 |
| 56 | SYK | 1.29464486 |
| 57 | JAK1 | 1.28352701 |
| 58 | PKN2 | 1.27704173 |
| 59 | EPHB1 | 1.22409472 |
| 60 | CDK7 | 1.20430036 |
| 61 | PLK3 | 1.19788157 |
| 62 | BRAF | 1.18638789 |
| 63 | NEK9 | 1.18635605 |
| 64 | CHUK | 1.18167727 |
| 65 | STK39 | 1.16087078 |
| 66 | SMG1 | 1.15494679 |
| 67 | TGFBR2 | 1.14357400 |
| 68 | IKBKB | 1.13121993 |
| 69 | PIM1 | 1.11658385 |
| 70 | DYRK1B | 1.10658647 |
| 71 | RPS6KA4 | 1.08925721 |
| 72 | MAP2K3 | 1.06306406 |
| 73 | AURKA | 1.05922110 |
| 74 | NUAK1 | 1.03743912 |
| 75 | ITK | 1.03030289 |
| 76 | TRIB3 | 1.00465923 |
| 77 | MAP2K2 | 1.00069581 |
| 78 | CSK | 0.99520900 |
| 79 | EIF2AK1 | 0.99507718 |
| 80 | MKNK1 | 0.98663408 |
| 81 | ATM | 0.97689188 |
| 82 | CDK1 | 0.96945495 |
| 83 | CDK2 | 0.96197988 |
| 84 | NLK | 0.93610742 |
| 85 | KSR1 | 0.92370999 |
| 86 | CDK4 | 0.90588387 |
| 87 | TLK1 | 0.89021387 |
| 88 | NEK2 | 0.88383263 |
| 89 | OXSR1 | 0.88124293 |
| 90 | LATS2 | 0.86496335 |
| 91 | MTOR | 0.84193541 |
| 92 | STK4 | 0.83994959 |
| 93 | CDK6 | 0.80887372 |
| 94 | CDK9 | 0.80143463 |
| 95 | MKNK2 | 0.79710167 |
| 96 | MAP3K3 | 0.79510715 |
| 97 | LYN | 0.78232454 |
| 98 | JAK2 | 0.74405674 |
| 99 | CDK8 | 0.71900831 |
| 100 | ZAK | 0.71884955 |
| 101 | SIK1 | 0.71384430 |
| 102 | MAP3K13 | 0.71308345 |
| 103 | MAPK11 | 0.71227007 |
| 104 | LMTK2 | 0.69906244 |
| 105 | WNK4 | 0.68448827 |
| 106 | CLK1 | 0.68260885 |
| 107 | LCK | 0.67770451 |
| 108 | PIM2 | 0.66193324 |
| 109 | PASK | 0.65900706 |
| 110 | PIK3CG | 0.64948188 |
| 111 | AKT2 | 0.64607840 |
| 112 | STK16 | 0.62855939 |
| 113 | MAP3K8 | 0.60523575 |
| 114 | PDK2 | 0.60179978 |
| 115 | TRPM7 | 0.59806795 |
| 116 | MAP3K9 | 0.57729014 |
| 117 | HCK | 0.55309518 |
| 118 | PAK4 | 0.54624972 |
| 119 | MST1R | 0.54417301 |
| 120 | MAPKAPK3 | 0.54029845 |
| 121 | BMX | 0.53260067 |
| 122 | MAP3K7 | 0.53133674 |
| 123 | MATK | 0.52745242 |
| 124 | RIPK4 | 0.52514346 |
| 125 | PNCK | 0.51282626 |
| 126 | MAP2K6 | 0.50268561 |
| 127 | PRKCI | 0.50087003 |
| 128 | MELK | 0.49904390 |
| 129 | BRD4 | 0.49726125 |
| 130 | DMPK | 0.49343177 |
| 131 | STK3 | 0.48775025 |
| 132 | NME2 | 0.47857260 |
| 133 | AURKB | 0.47838567 |
| 134 | FGFR3 | 0.47583052 |
| 135 | DYRK3 | 0.47339370 |
| 136 | ALK | 0.47083804 |
| 137 | EIF2AK2 | 0.46658792 |
| 138 | RIPK1 | 0.46143076 |
| 139 | PRKDC | 0.45440513 |
| 140 | SCYL2 | 0.45307107 |
| 141 | PRKAA1 | 0.44758450 |
| 142 | CAMK1G | 0.43659850 |
| 143 | GSK3B | 0.43477369 |
| 144 | CSNK2A2 | 0.43384944 |
| 145 | PAK1 | 0.42802326 |
| 146 | PRKCQ | 0.42646528 |
| 147 | MAPK14 | 0.42404594 |
| 148 | CSNK1E | 0.42365889 |
| 149 | MYLK | 0.42134224 |
| 150 | TESK2 | 0.41440505 |
| 151 | MARK3 | 0.40740356 |
| 152 | LATS1 | 0.40503248 |
| 153 | RPS6KA1 | 0.40499340 |
| 154 | ABL1 | 0.38254095 |
| 155 | ARAF | 0.38126891 |
| 156 | MAPK10 | 0.37508338 |
| 157 | HIPK2 | 0.37264362 |
| 158 | MAPK12 | 0.37198975 |
| 159 | VRK1 | 0.36318252 |
| 160 | CAMK1D | 0.36219605 |
| 161 | CDK11A | 0.36069935 |
| 162 | TAOK2 | 0.35580456 |
| 163 | CDK15 | 0.34696792 |
| 164 | MAPK4 | 0.32843458 |
| 165 | TXK | 0.32453756 |
| 166 | PRKAA2 | 0.31973051 |
| 167 | CDK18 | 0.31518751 |
| 168 | ATR | 0.31161682 |
| 169 | RPS6KB1 | 0.28431336 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cell cycle_Homo sapiens_hsa04110 | 3.13846084 |
| 2 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.00536729 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.99777621 |
| 4 | RNA transport_Homo sapiens_hsa03013 | 2.52947728 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.49330674 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 2.45259986 |
| 7 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.44056666 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.41407641 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.34770143 |
| 10 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.34491763 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.20994613 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.15816486 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.12543789 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.07424967 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.00487092 |
| 16 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.92053866 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.91650490 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.86197568 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77135847 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.76396374 |
| 21 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.68546852 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.65133101 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.62938929 |
| 24 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.57605431 |
| 25 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.52741188 |
| 26 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.50549160 |
| 27 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.47704161 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.43254598 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.41163786 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.40749764 |
| 31 | Basal transcription factors_Homo sapiens_hsa03022 | 1.34636629 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33484912 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.31923513 |
| 34 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.30753513 |
| 35 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.28655172 |
| 36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.26920484 |
| 37 | RNA degradation_Homo sapiens_hsa03018 | 1.25101810 |
| 38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.24433004 |
| 39 | Measles_Homo sapiens_hsa05162 | 1.23860677 |
| 40 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.23648744 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.23088169 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21321727 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.20918438 |
| 44 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.20590296 |
| 45 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.20402305 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.19655294 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16365056 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15854526 |
| 49 | Thyroid cancer_Homo sapiens_hsa05216 | 1.14291184 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.14131977 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 1.13283225 |
| 52 | DNA replication_Homo sapiens_hsa03030 | 1.13170400 |
| 53 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12418324 |
| 54 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.10999648 |
| 55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09960299 |
| 56 | RNA polymerase_Homo sapiens_hsa03020 | 1.07763378 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 1.07493228 |
| 58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.07237973 |
| 59 | Asthma_Homo sapiens_hsa05310 | 1.06821860 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.06685145 |
| 61 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.04105013 |
| 62 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.03872837 |
| 63 | Pertussis_Homo sapiens_hsa05133 | 1.03447119 |
| 64 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.02670865 |
| 65 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.01787981 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.01618990 |
| 67 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.99193339 |
| 68 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.98443590 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.98225532 |
| 70 | Base excision repair_Homo sapiens_hsa03410 | 0.97888719 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.97765750 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.96585944 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.96315037 |
| 74 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.96308848 |
| 75 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.95138643 |
| 76 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.93968049 |
| 77 | Purine metabolism_Homo sapiens_hsa00230 | 0.93735834 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.93197359 |
| 79 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92586362 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.91013675 |
| 81 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.89170323 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88452438 |
| 83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.88091459 |
| 84 | Tuberculosis_Homo sapiens_hsa05152 | 0.84257058 |
| 85 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.83707790 |
| 86 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81750629 |
| 87 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.81355196 |
| 88 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.80372332 |
| 89 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.80159880 |
| 90 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77692298 |
| 91 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.76192681 |
| 92 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.75641802 |
| 93 | Proteasome_Homo sapiens_hsa03050 | 0.75158769 |
| 94 | Mismatch repair_Homo sapiens_hsa03430 | 0.74526170 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72174449 |
| 96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71817493 |
| 97 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.71618058 |
| 98 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.71471171 |
| 99 | Ribosome_Homo sapiens_hsa03010 | 0.71308546 |
| 100 | Hepatitis B_Homo sapiens_hsa05161 | 0.70749434 |
| 101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70562235 |
| 102 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70283295 |
| 103 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.70128074 |
| 104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69661307 |
| 105 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.69431392 |
| 106 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.69326711 |
| 107 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68946543 |
| 108 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.67708264 |
| 109 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.67671888 |
| 110 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.67582430 |
| 111 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.67064774 |
| 112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66297810 |
| 113 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.65855805 |
| 114 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.65694415 |
| 115 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65442491 |
| 116 | Adherens junction_Homo sapiens_hsa04520 | 0.64567513 |
| 117 | Homologous recombination_Homo sapiens_hsa03440 | 0.64446775 |
| 118 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63445571 |
| 119 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63263889 |
| 120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.62981246 |
| 121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62108413 |
| 122 | Protein export_Homo sapiens_hsa03060 | 0.61328695 |
| 123 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61294612 |
| 124 | Retinol metabolism_Homo sapiens_hsa00830 | 0.61214839 |
| 125 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.60078375 |
| 126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59460594 |
| 127 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58860035 |
| 128 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58314517 |
| 129 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58309927 |
| 130 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57909758 |
| 131 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.57772352 |
| 132 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.57689905 |
| 133 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.56452287 |
| 134 | Alcoholism_Homo sapiens_hsa05034 | 0.56191219 |
| 135 | Allograft rejection_Homo sapiens_hsa05330 | 0.55815571 |
| 136 | Shigellosis_Homo sapiens_hsa05131 | 0.55778778 |
| 137 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54592021 |
| 138 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54454206 |
| 139 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54282137 |
| 140 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54230168 |
| 141 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53369814 |
| 142 | Bladder cancer_Homo sapiens_hsa05219 | 0.52593706 |
| 143 | Glioma_Homo sapiens_hsa05214 | 0.49770397 |
| 144 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49764406 |
| 145 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49536907 |
| 146 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48620338 |
| 147 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48235748 |
| 148 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47548774 |
| 149 | Prostate cancer_Homo sapiens_hsa05215 | 0.46695272 |
| 150 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46681577 |
| 151 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45276344 |
| 152 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45217676 |
| 153 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43535421 |
| 154 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.42505300 |
| 155 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.41910219 |
| 156 | Huntingtons disease_Homo sapiens_hsa05016 | 0.39871981 |
| 157 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.39656276 |
| 158 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35128451 |
| 159 | Parkinsons disease_Homo sapiens_hsa05012 | 0.32565947 |
| 160 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32071059 |
| 161 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32047484 |
| 162 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31487565 |
| 163 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30811348 |
| 164 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.25860599 |
| 165 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.25301726 |
| 166 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.24098731 |
| 167 | Insulin resistance_Homo sapiens_hsa04931 | 0.23596260 |
| 168 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.19426769 |

